SANOFI-AVENTIS
FDA Registration(s)#
Registration, FEI, Name table| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|
| 3003496686 | 3000719690 | Sanofi-Aventis U.S. LLC | 1 | N | 2020-04-25 | 55 Corporate Drive BRIDGEWATER NJ US 08807 |
Registered Device Listings#
Registration key, Listing key, Premarket submission table| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|
| 61505 | 1804950956 | K131159 | SMARTRELIEF | NUH | 2013-07-25 |
Product Codes Associated With Registrations#
Product code, Registration listing records, Latest decision table| Product code | Registration listing records | Latest decision |
|---|
| NUH | 1 | 2013-07-25 |
NDC#
Sanofi-Aventis U.S. LLC
isatuximab
Sanofi-Aventis U.S. LLC
isatuximab
Sanofi-Aventis U.S. LLC
clopidogrel
Sanofi-Aventis U.S. LLC
clopidogrel
Sanofi-Aventis U.S. LLC
Primaquine Phosphate
sanofi-aventis U.S. LLC
sodium ferric gluconate complex
sanofi-aventis U.S. LLC
sodium ferric gluconate complex
Sanofi-Aventis U.S. LLC
Dronedarone
Sanofi-Aventis U.S. LLC
Fexinidazole
Sanofi-Aventis U.S. LLC
rasburicase
Sanofi-Aventis U.S. LLC
rasburicase
Sanofi-Aventis U.S. LLC
zolpidem tartrate
Sanofi-Aventis U.S. LLC
zolpidem tartrate
Sanofi-Aventis U.S. LLC
zolpidem tartrate
Sanofi-Aventis U.S. LLC
insulin glargine and lixisenatide
Sanofi-Aventis U.S. LLC
cabazitaxel
sanofi-aventis U.S. LLC
ziv-aflibercept
sanofi-aventis U.S. LLC
ziv-aflibercept
Sanofi-Aventis U.S. LLC
irbesartan
Sanofi-Aventis U.S. LLC
irbesartan
Sanofi-Aventis U.S. LLC
irbesartan and hydrochlorothiazide
Sanofi-Aventis U.S. LLC
irbesartan and hydrochlorothiazide
Sanofi-Aventis U.S. LLC
PLERIXAFOR
Sanofi-Aventis U.S. LLC
insulin glargine
Sanofi-Aventis U.S. LLC
insulin glargine
Sanofi-Aventis U.S. LLC
alirocumab
Sanofi-Aventis U.S. LLC
alirocumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
Dupilumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
sarilumab
Sanofi-Aventis U.S. LLC
insulin lispro
Sanofi-Aventis U.S. LLC
insulin lispro
Sanofi-Aventis U.S. LLC
insulin lispro
Sanofi-Aventis U.S. LLC
insulin aspart-szjj
82 records. Showing 1-40. Next
PMA#
1976-06-28
SANOFI AVENTIS U.S. LLC
Applications#
SANOFI-AVENTIS U.S. LLC
SANOFI AVENTIS US
SANOFI-AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI-AVENTIS US
SANOFI-AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS
SANOFI AVENTIS US
SANOFI-AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
SANOFI AVENTIS US
149 records. Showing 1-40. Next
GUDID#
Sanofi-Aventis Deutschland GmbH
2017-06-02
Sanofi-Aventis Deutschland GmbH
2020-11-23